Heraeus Vadnais to acquire Synovis unit for $29.5M

01/8/2008 | Star Tribune (Minneapolis-St. Paul, Minn.)

Synovis Life Technologies has agreed to sell its interventional unit that makes components for heart defibrillators and pacemakers to Heraeus Group division Heraeus Vadnais for $29.5 million. The sale will allow Synovis to focus on the field of soft-tissue repair, the company's CEO said.

View Full Article in:

Star Tribune (Minneapolis-St. Paul, Minn.)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Corporate Counsel - Healthcare Law Group
Genentech
South San Francisco, CA